KLSE (MYR): YSPSAH (7178)
You're accessing 15 mins delay data. Turn on live stream now to enjoy real-time data!
Last Price
2.52
Today's Change
-0.01 (0.40%)
Day's Change
2.52 - 2.52
Trading Volume
12,000
Ann. Date | Date | Type | Units | Price | View |
---|
China National Pharmaceutical Group Corp (SINOPHARM), a Chinese state-owned enterprise, announced on Wednesday that data from late-stage clinical trials for its Covid-19 vaccine are «BETTER THAN EXPECTED», Reuters reported.
In Morocco, Dr. Abdelhakim Yahyane, a member of the National Scientific Advisory Committee on Vaccination, told Yabiladi earier this week that vaccine trials in the country «have REACHED THE FINAL PHASE».
We are impatiently awaiting the end of this process, which could probably happen BY NEXT WEEK
https://en.yabiladi.com/articles/details/101544/conducted-morocco-among-others-sinopharm-s.html
2020-11-13 21:53
PM: No call to reject 2021 Budget just to bring about polls
"There is no need to do that (reject the 2021 Budget). If you ask me, I could have yesterday advised the Yang di-Pertuan Agong Al-Sultan Abdullah Ri'ayatuddin Al-Mustafa Billah Shah, to dissolve Parliament so that a general election can be held.
"But we all know that the problem is Covid-19. InsyaAllah, if He allows it, when the pandemic is over, we can hold a general election.
Muhyiddin added that the 2021 Budget, worth RM322.5 billion which was passed at the policy level in Parliament on Thursday, is aimed at easing the burden of the people and restoring the country's economy.
"I hope the 2021 Budget will be approved at the Dewan Rakyat and subsequently at the Dewan Negara. This is to ensure that the people will receive the assistance that they need during this tough time."
https://www.nst.com.my/news/politics/2020/11/645117/pm-no-call-reject-2021-budget-just-bring-about-polls
2020-11-29 21:26
No significant change to reject budget at committee level: Dr M
FORMER Prime Minister (PM) Tun Dr Mahathir Mohamad said no significant change can be achieved if the proposed Budget 2021 is rejected at the committee level debate session.
“Rejecting the budget at the committee level, as it is said to be done, will not bring any significant impact on the government nor the proposed budget.
“It is just an attempt to divert the criticisms of the people who are disappointed with the attitude of the Opposition,” Dr Mahathir said in a statement today.
https://themalaysianreserve.com/2020/11/27/no-significant-change-to-reject-budget-at-committee-level-dr-m/
2020-11-29 21:36
UAE says Sinopharm vaccine has 86% efficacy against COVID-19
DUBAI (Reuters) - An experimental coronavirus vaccine developed by China’s Sinopharm has 86% efficacy against the virus, the United Arab Emirates health ministry said on Wednesday, citing an interim analysis of a human trial underway there.
The Gulf Arab state in July started Phase 3 clinical trials of the vaccine, developed by Beijing Institute of Biological Product, a unit of Sinopharm’s China National Biotec Group (CNBG). In September, the UAE approved its emergency use for certain groups.
The analysis also shows “99% seroconversion rate of neutralizing antibody and 100% effectiveness in preventing moderate and severe cases of the disease”, the ministry said in a statement carried by the state news agency.
“The analysis shows no serious safety concerns,” it said.
It also said it had officially registered the vaccine, without elaborating, and that 31,000 volunteers across 125 nationalities participated in the UAE trial.
https://www.reuters.com/article/health-coronavirus-emirates/update-1-uae-says-sinopharm-vaccine-has-86-efficacy-against-covid-19-idUSL1N2IP09V
2020-12-09 15:17
United Arab Emirates Claims China’s Sinopharm Vaccine Is 100% Effective At Preventing Moderate And Severe Covid-19
TOPLINE The experimental vaccine developed by China National Pharmaceutical Group, also known as Sinopharm, is 86% effective at preventing Covid-19 infection and 100% effective at preventing severe and moderate disease, health officials from the United Arab Emirates announced Wednesday, although with scarce detail provided about the trial.
The UAE health ministry cited an interim analysis of a late-stage clinical trial involving 31,000 volunteers as the source of its information, though neither they nor Sinopharm provided any data from the trial to validate the claims such as how many participants were infected or how many actually received the vaccine.
The ministry said “no serious safety concerns” were observed, though, again, no information on side effects was provided.
The ministry said the announcement is a “significant vote of confidence by the UAE’s health authorities in the safety and efficacy of this vaccine.”
The ministry added that it had officially registered the vaccine at the request of the manufacturer, which it says could eventually lead to the shot’s widespread authorization.
https://www.forbes.com/sites/roberthart/2020/12/09/united-arab-emirates-claims-chinas-sinopharm-vaccine-is-100-effective-at-preventing-moderate-and-severe-covid-19/?sh=2a60fb42595c
2020-12-09 22:24
why so many people keep posting the same vaccine news all over the place? cannot ban them?
here we want to know whether yspsah got vaccine or not
2020-12-10 22:01
A Guide to Investing in Healthcare Companies
Low tier: IHH, TopGlove, Supermaxm Pharmaniaga
High tier: YSPSAH, Apex Healthcare, Duopharma
2021-06-10 15:03
This is super cheap. Dividend announcement is 8 cents, current price means this is 4% ROI. NTA is well above 2.40. I just parked my orders to buy in, this is a really good steal.
2021-07-14 09:51
Nothing much to comment about this stock.Sold some last year.Should have sold all. Dividen is nothing to shout about.
2021-08-29 19:11
gamblers ? i thought most of us will forget we owned this stock until we received a cheque notice about the dividend . hahaha
2021-09-01 16:19
As i mentioned, hold long term for good profit
Refered to my message on 30/8/21
2021-09-01 16:59
Hold for lomg term.
2 years like that.
You will thanks me.
Just a cup of starbuck belanja me.
2021-09-22 11:31
Guide to Investing in Bursa Healthcare 2022
1. Kotra Industries 2. YSP 3. ???
2022-04-02 21:53
Buy-side has no more idea. They will pump all the healthcare stocks remaining
2022-11-04 11:22
walao ehh..wat happen to YSP
Suddenly surge to fly so high today!! Happy Happy
2022-12-13 12:48
Finally this share has released it's true potential power. I have been waiting years for it to shine
2023-01-03 19:55
Apex Healthcare + YSP + Kotra Industries = Dream Healthcare Portfolio 2023
2023-02-23 16:34
Integrity. Intelligent. Industrious. 3iii (iiinvestsmart)$â¬Â£Â¥
Security LastPr PE DY% Divcts ROE ttm-marg
YSPSAH (Pharmaceuticals) 2.35 9.63 3.4 8 9.25 10.3
2 months ago
NPRA1985
Sinopharm Vaccine (linked to Kanger) is on track for full approval in November or December
“The most promising of these, developed by Wuhan-based Sinopharm, is already being given to frontline workers in the United Arab Emirates. According to Wu Guizhen, chief biosafety expert at the Chinese Center for Disease Control and Prevention, Sinopharm’s candidate is on track for full approval this month or next.”
https://www.foreignaffairs.com/articles/united-states/2020-11-05/china-winning-vaccine-race?amp=true
2020-11-07 02:29